1. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

   • Robin C. Stuart-Harris
   • Peter G. Harper
   • Eve Wiltshaw

   Original Articles Pages: 69 - 72

2. Antileukemic effect of alkyl phospholipids

   • Yoshio Honma
   • Takashi Kasukabe
   • Hiroaki Nomura

   Original Articles Pages: 73 - 76

3. Antileukemic effect of alkyl phospholipids

   • Yoshio Honma
   • Takashi Kasukabe
   • Hiroaki Nomura

   Original Articles Pages: 77 - 79

4. Combination chemotherapy for the treatment of Hodgkin's disease in relapse

   • David J. Straus
   • Jane Myers
   • Bayard D. Clarkson

   Original Articles Pages: 80 - 85

5. Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W-7, and W-13

   • Jiann-Wu Wei
   • Robert A. Hickie
   • David J. Klaassen

   Original Articles Pages: 86 - 90

6. Prevention of adriamycin toxicity

   • Allen R. Banks
   • Ted Jones
   • Nicholas R. Bachur

   Original Articles Pages: 91 - 93

7. A phase II study of m-AMSA in patients with malignant mesothelioma

   • Geoffrey Falkson
   • Daniel A. Vorobiof
   • Harvey J. Lerner

   Original Articles Pages: 94 - 97

8. Delivery of therapeutic doses of doxorubicin to the mouse lung using lung-accumulating liposomes proves unsuccessful

   • R. M. Abra
   • C. Anthony Hunt
   • J. H. Peters

   Original Articles Pages: 98 - 101

9. Mechanism of cytotoxic activity of 5′-deoxy-5-fluorouridine

   • R. Douglas Armstrong
   • Kevin M. Connolly
   • Ed Cadman

   Original Articles Pages: 102 - 105

10. Combination chemotherapy (high-dose methotrexate with citrovorum factor rescue, mechlorethamine, and procarbazine) in non-small cell lung cancer

    • R. R. Bhasin
    • C. P. Nogeirie

    Original Articles Pages: 106 - 107

11. Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer

    • Krsto Kolarić
    • Anton Roth

    Original Articles Pages: 108 - 112

12. Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures

    • Alan T. McGown
    • Timothy H. Ward
    • Brian W. Fox

    Original Articles Pages: 113 - 116

13. Guanine ribonucleotide depletion in mammalian cells

    • Binh T. Nguyen
    • Marvin B. Cohen
    • Wolfgang Sadée

    Original Articles Pages: 117 - 119

14. Energy-dispersive X-ray fluorescence determination of platinum in plasma, urine, and cerebrospinal fluid of patients administered cis-dichlorodiammineplatinum(II)

    • William E. Seifert Jr.
    • David J. Stewart
    • Richard M. Caprioli

    Original Articles Pages: 120 - 123

15. The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF₁ mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity

    • David A. Shiba
    • Robert J. Weinkam

    Original Articles Pages: 124 - 129

16. Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF)

    • Sharon K. Shipp
    • Hyman B. Muss
    • Douglas Case

    Original Articles Pages: 130 - 133

17. Sequential inhibition of polyamine synthesis

    • Raymond P. Warrell Jr.
    • Craig J. Coonley
    • Joseph H. Burchenal

    Original Articles Pages: 134 - 136

18. Selective sensitivity of malignant cells to Adriamycin

    • P. M. Kimball
    • S. Hixon
    • L. Arcolano

    Short Communication Pages: 137 - 138